ADME Review. Dr. Joe Ritter Associate Professor of Pharmacology

Similar documents
Excretion of Drugs. Prof. Hanan Hagar Pharmacology Unit Medical College

Drug Distribution. Joseph K. Ritter, Ph.D., Assoc. Prof. Medical Sciences Building, Room

Unit 2b: EXCRETION OF DRUGS. Ms.M.Gayathri Mpharm (PhD) Department of Pharmaceutics Krishna Teja Pharmacy college Subject code: 15R00603 (BPPK)

Renal Excretion of Drugs

CLINICAL PHARMACOKINETICS INDEPENDENT LEARNING MODULE

INTRODUCTION TO PHARMACOKINETICS

LD = (Vd x Cp)/F (Vd x Cp)/F MD = (Css x CL x T)/F DR = (Css x (Vm-DR))/Km Css = (F x D)/(CL x T) (Km x DR)/(Vm DR)

Pharmacokinetics of Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Renal Function. 1. Glomerular filtration 2. Active tubular secretion 3. Passive tubular reabsorption 4. Excretion

General Principles of Pharmacology and Toxicology

Basic Concepts in Pharmacokinetics. Leon Aarons Manchester Pharmacy School University of Manchester

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA First Exam. Fall 2004

Industrial Toxicology

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Pharmacokinetics. Karim Rafaat

PHAR 7632 Chapter 16

Pharmacokinetics Dr. Iman Lec. 3

Pharmacokinetics in Drug Development. Edward P. Acosta, PharmD Professor & Director Division of Clinical Pharmacology Director, CCC PK/PD Core

Chapter 1. Introduction

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

It the process by which a drug reversibly leaves blood and enter interstitium (extracellular fluid) and/ or cells of tissues.

Pharmacokinetics I. Dr. M.Mothilal Assistant professor

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Adjusting phenytoin dosage in complex patients: how to win friends and influence patient outcomes

Drug elimination and Hepatic clearance Chapter 6

DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA

PHA5128 Dose Optimization II Case Study I Spring 2013

Regulation of fluid and electrolytes balance

PHA First Exam Fall 2003

PHA Final Exam Fall 2006

Metabolism. Objectives. Metabolism. 26 July Chapter 28 1

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

WHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION

Name: UFID: PHA Exam 2. Spring 2013

Lippincott Questions Pharmacology

RENAL PHYSIOLOGY, HOMEOSTASIS OF FLUID COMPARTMENTS

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Rational Dose Prediction. Pharmacology. φαρμακον. What does this mean? pharmakon. Medicine Poison Magic Spell

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

DRUG DISTRIBUTION. Distribution Blood Brain Barrier Protein Binding

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine.

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

Pharmacokinetics PCTH 325. Dr. Shabbits September 12, C t = C 0 e -kt. Learning Objectives

PHARMACOKINETICS SMALL GROUP I:

Renal Clearance. Dr. Eman El Eter

KD02 [Mar96] [Feb12] Which has the greatest renal clearance? A. PAH B. Glucose C. Urea D. Water E. Inulin

RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D.

Chapter 27: WATER, ELECTROLYTES, AND ACID-BASE BALANCE

BASIC PHARMACOKINETICS

Effects of Renal Disease on Pharmacokinetics

TOXICOKINETICS; DISPOSITION OF XENOBIOTICS (Absorption, Distribution and Excretion of xenobiotics)

Terminology. Terminology. Terminology. Molarity number of moles of solute / Liter of solution. a) Terminology b) Body Fluid Compartments

Introduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

GENERAL PHARMACOLOGY

ENVIRONMENTAL TOXICOLOGY

General Principles of Pharmacology and Toxicology

Chapter 3 Drug Absorption and Bioavailability

BIOL 2402 Renal Function

Principles of Anatomy and Physiology

Importance of drug antagonism (i) Correcting adverse effects of drugs (ii) Treating drug poisoning. e.g. Morphine with naloxone, organophosphate

Answers and Explanations

The principal functions of the kidneys

BIOPHARMACEUTICS and CLINICAL PHARMACY

Ch 19: The Kidneys. Functional unit of kidneys:?? Developed by John Gallagher, MS, DVM

Urinary System. consists of the kidneys, ureters, urinary bladder and urethra

Ch 17 Physiology of the Kidneys

Introduction to Pharmacokinetics (PK) Anson K. Abraham, Ph.D. Associate Principal Scientist, PPDM- QP2 Merck & Co. Inc., West Point, PA 5- June- 2017

Renal Physiology II Tubular functions

Determination of bioavailability

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Renal physiology D.HAMMOUDI.MD

General Pharmacology MCQs

Pharmacodynamics & Pharmacokinetics 1

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

What is pharmacokinetics?

DRUG ELIMINATION II BILIARY EXCRETION MAMMARY, SALIVARY AND PULMONARY EXCRETION

The importance of clearance

Physio 12 -Summer 02 - Renal Physiology - Page 1

Introduction to Pharmacology

Nonlinear Pharmacokinetics

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Biopharmaceutics. Tips Worth Tweeting. Contributor: Sandra Earle

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist

Distribution. Definition. Distribution is the the API s movement to the tissues fromthesytemic circulation.

Click to edit Master title style

Mechanisms of Drug Action

Name: Class: "Pharmacology NSAIDS (1) Lecture

Chapter-V Drug use in renal and hepatic disorders. BY Prof. C.Ramasamy, Head, Dept of Pharmacy Practice SRM College of Pharmacy, SRM University

Pharmacokinetic Phase

EVE 491/591 Toxicology. Toxicant Distribution 2/20/2014

UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE

Excretion Chapter 29. The Mammalian Excretory System consists of. The Kidney. The Nephron: the basic unit of the kidney.

Introduction to the kidney: regulation of sodium & glucose. Dr Nick Ashton Senior Lecturer in Renal Physiology Faculty of Biology, Medicine & Health

Pharmacokinetic Phase

PHA 5128 Spring 2009 First Exam (Version B)

CHAPTER-III PHARMACOKINETIC DRUG INTERACTIONS

Basic Concepts of TDM

Transcription:

ADME Review Dr. Joe Ritter Associate Professor of Pharmacology 828-1022 jkritter@vcu.edu What percent of a weak base (pka = 7.5) and weak acid (pka = 3.5) will be respectively ionized in urine of ph 5.5? a. 1% and 1% b. 9% and 91% 50% and 50% c. 91% and 9% d. 99% and 99% ph pka = log Base/Acid [Acid] 5.5 3.5 = 2 log 100 = 2 A - / HA = 100/1 [Base] 5.5-7.5 = -2 log.01 = -2 B / BH+ = 1/100 1

Fraction in Acid form (HA) PH 1.0 0.8 Weak Acids % ionization of aspirin Weak Bases % ionization of codeine 3 units > pk a 99.9% Log [A /HA = 1000/1] 0.1% Log [B/BH + = 1000/1] 2 units > pk a 99% Log [A /HA = 100/1] 1% Log [B/BH + = 100/1] 3 units > pk a 90.9% Log [A /HA = 10/1] 9% Log [B/BH + = 10/1] ph = pk a 50% Log [A /HA = 1/1] 50% Log [B/BH + = 1/1] 1 units < pk a 9% Log [A /HA = 1/10] 90.9% Log [B/BH + = 1/10] 2 units < pk a 1% Log [A /HA = 1/100] 99% Log [B/BH + = 1/100] 3 units < pk a 0.1% Log [A /HA = 1/1000] 99.9% Log [B/BH + = 1/1000] COOH OH -H +H COO- OH CH 3 O pka = 3.5 pka = 7.5 Fraction in Acid form (BH+) O HO 1.0 0.8 N CH 3 +H -H CH 3 O 0.6 0.6 0.4 0.4 0.2 0.2 0.0 0.0 10 0 2 4 6 8 10 0 2 4 6 8 10 ph ph ph ph O HO H N CH 3 Select the route of administration that will produce the slowest onset of drug action, most rapid onset of action and a first-pass liver effect a. oral b. intravascular c. rectal d. intramuscular e. subcutaneous Major first pass effect Slowest onset Most rapid onset Slight first pass effect 2

Select the statements that are not true about the advantages and disadvantages of parenteral and enteral routes of drug administration. a. enteral advantages: safe, economical, high bioavailability, rapid onset of action b. enteral disadvantages: slow onset of action, low bioavailability, first pass liver effect, patient compliance c. parenteral advantages: high bioavailability, fast onset of action, patient compliance, safe, economical d. parenteral disadvantages: expensive, more dangerous, patient compliance, first pass liver effect Select the mechanism by which small water soluble agents, most lipophilic drugs and large molecular weight hormones cross membranes. a. filtration Small water solubles b. active transport c. facilitated transport d. passive diffusion e. receptor mediated endocytosis Most lipophilic drugs [major mechanism] Large MW hormones 3

Which of the following statements is not true about sublingual drug administration? a. by-pass portal circulation b. rapid onset of drug action c. excellent method of administering nitroglycerin and epinephrine d. good method for administering many drugs e. difficult to hold drugs here for significant periods of time Select the body water compartments that represent 60%, 40%, 20%, 16% and 4% of an individual's total body weight. a. total body water b. extracellular water c. intracellular water d. plasma water e. interstitial water 4 % 60% 16% 20% 40% 4

Thiopental has a duration of action because this agent is. a. short, rapidly excreted b. long, slowly excreted c. long, slowly metabolized d. short, rapidly redistributed e. short, rapidly metabolized f. long, slowly redistributed Phenobarbital poisoning is treated with to the extracellular ph and increase the clearance of phenobarbital. a. ammonium chloride decrease b. ammonium chloride increase c. sodium bicarbonate increase d. sodium bicarbonate decrease e. sodium hydroxide decrease 5

The distribution of drugs to the brain is limited as a result of. a. blood-brain barrier b. blood-csf barrier c. blood-extracellular barrier d. brain-csf barrier e. blood-intracellular barrier Arterial Blood Blood-Brain Barrier (capillary endothelium, astrocytic sheath) Blood-CSF Barrier (capillary endothelium, epithelium of choroid plexus) Extracellular Cerebrospinal Fluid Brain - CSF Fluid Compartment Barrier Compartment of Brain (ventricles and spaces of CNS) Select the agent that can produce fetal abortion, malformation, retardation, withdrawal and vaginal cancer later in life. a. cocaine b. ethanol c. thalidomide d. morphine Fetal abortion Withdrawal Retardation Malformation Withdrawal e. diethylstilbesterol Vaginal adenocarcinoma in latre life 6

Which of the following statements is not true about the interaction between chronic alcohol intake and acetaminophen (Tylenol). a. Alcohol induces the hepatic metabolism of acetaminophen. True b. Alcohol potentiates the hepatotoxicity of acetaminophen. c. Therapeutic levels of acetaminophen can produce liver damage in alcoholics. True d. Liver damage can be reduced with the administration of n- acetylcysteine. True e. The combination of alcohol and acetaminophen is not toxic in most alcoholics. False True All of the following drugs or conditions induce drug metabolism except? a. phenobarbital b. smoking c. chronic alcohol intake d. phenytoin e. cimetidine f. rifampin g. chloramphenicol 7

All of the following drugs or conditions inhibit drug metabolism except? a. aging b. liver disease c. cimetidine d. chloramphenical e. acute alcohol intake f. charcoal broiled food g. testosterone h. newborn From the list below select an agent that produces liver injury in slow acetylators and one that produces respiratory depression in patients with decreased plasma cholinesterase activity. a. chloramphenicol b. cimetidine c. succinylcholine d. aspirin e. phenobarbital Plasma cholinesterase activity None of these produce liver injury in slow acetylators (the antitubercular drug isoniazid produces liver injury in slow acetylators) 8

Select the P450 induced by ethanol, smoking, phenobarbital, isoniazid and rifampin. a. 2E1 b. 1A2 c. 2B6 d. 3A4 Induced by ethanol and isoniazid Induced by smoking and charbroiled foods Induced by phenobarbital and rifampin Induced by phenobarbital and rifampin Select the one agent that is not found in the urine after the administration of aspirin. a. salicylic acid b. salicyluric acid c. ether glucuronide of salicylic acid d. ester glucuronide of salicylic acid e. salicylacetic acid 9

Drug clearance is decreased by all of the following except. a. aging b. newborn c. liver disease d. kidney disease e. heart disease f. smoking g. phenobarbital Kidney function can be assessed by determining the glomerular filtration rate (GFR) and the renal plasma flow (RPF) by measuring the clearance of? a. creatinine and inulin b. para-aminohippuric acid (PAH) and probenecid c. inulin and PAH d. creatinine and probenecid e. inulin and probenecid f. creatinine and PAH GFR = creatinine or inulin Renal plasma flow = PAH 10

When renal drug clearance is greater than the GFR the drug is primarily by the nephron. a. secreted b. reabsorbed c. filtered d. filtered, secreted and reabsorbed Which of the following drugs are readily cleared as they pass through the liver? a. propranolol b. lidocaine c. morphine d. tolbutamide e. phenobarbital These drugs are all high extraction, high intrinsic clearance, subject to high first pass effect, flow-limited 11

Select the agent that can be used to reduce the enterohepatic cycling of drugs. a. propranolol b. cholestyramine c. morphine d. steroids e. phenobarbital Bile acid binding resin (sequestrant), binds tightly to bile acid and carries it out in feces, reduced enterohepatic cycling of bile acids, drugs, lipid soluble vitamins, common source of drug interaction Nitrous oxide has a low λ, a short duration of action and a rapid rate of clearance. a. high, long, low b. low, short, rapid c. high, short, rapid d. low, long, low e. high, long, high 12

Select the agents that would be useful in reducing the high plasma uric acid levels associated with gout. a. probenecid b. aspirin c. cimetidine d. phenobarbital e. sodium bicarbonate Both these agents block the carrier-mediated reabsorption of uric acid from glomerular filtrate in the proximal tubules of the kidney If a drug has a half-life of 6 hours how long will it take to clear 100% of this drug and how many doses given at half-life intervals will be needed to reach 94% of the C SS? a. 42 h 4 b. 30 h 6 c. 48 h 5 d. 24 h 7 e. 36 h 3 Percent Halflife Eliminated 0 100 1 50 2 25 3 13 4 6 5 3 6 2 7 1 Half life Percent Accum. 0 0 1 50 2 75 3 87 4 94 5 97 6 98 7 99 7 T1/2s x 6 hrs = 42 hrs 4 T1/2s = 94% of Css42 hrs 13

Select the incorrect formula. a. Vd = Q / Co b. CL = ke Vd c. t 1 / 2 =.693 / ke d. Css = [F x D] / [CL T] e. t 1/2 = [.693 Vd] / CL f. CL = [.693 t 1 / 2 ] / Vd g. LD = [Vd Cp] / F h. MD = [Css CL T] / F i. CL = [.693 Vd] / t 1 / 2 The time course of a drug's plasma plateau (Css) is altered by all of the following factors except? Y a. liver disease Y b. kidney disease c. a loading dose followed Y (exception) by a maintenance dose at constant intervals d. induction of hepatic drug metabolism Y Y e. inhibition of hepatic drug metabolism N f. change in dose interval N g. change in dose level Y h. aging Y i. heart disease Any factor that affects half life will affect the time course including t 1/2 = [.693 Vd] / CL 14

The magnitude of a drug's plasma plateau (Css) is altered by all of the following factors except? a. change in dose interval b. change in dose level c. change in drug clearance Css = F D d. change in drug bioavailability CL T e. liver disease f. kidney disease g. aging Css is affected by all of the factors h. heart disease i. route of drug administration The dose of drug should be reduced in all of the following except? a. elderly patients b. infants c. liver disease d. kidney disease e. smokers f. alcoholics (without liver damage) Possibly (can act as a inhibitor but it is also an inducer 15

What drug dose must be given at half-life intervals to obtain a Css of 300 mg? a. 50 mg b. 100 mg c. 150 mg d. 200 mg e. 300 mg When T = T1/2, accumulation factor is 2 such that at steady state, peak amount in body will be 2D, trough amount in body will be 1D and the average in the body will be 1.5D [if dose interval is equal to drug s half-life] 400 400 For D = 200 mg, 350 200 300 175 200 150 100 Dose 1 2 3 4 7 8 The desired Css of drug X is 300 mg. Eight hours after administering a single 300 mg dose of drug X there is only 75 mg of drug X remaining in the patient. What loading dose (LD), maintenance dose (MD) and dose interval (DI) would you recommend to reach and maintain the 300 mg Css as quickly as possible? LD MD DI a. 400 mg 200 mg 4 h b. 600 mg 300 mg 4 h c. 300 mg 300 mg 8 h d. 400 mg 200 mg 8 h e. 600 mg 300 mg 8 h After 8 hr, 25% remains. 2 half lives have passed T1/2 =4 hrs 16

A 400 mg dose of drug X is administered to a 220 pound man. The peak plasma level (Cp) of drug X is 1 mg/l. The Vd of drug X is? a. 4 L b. 40 L c. 400 L d. 25 L e. 250 L Vd = Q / Cp = (400 mg)/(1 mg/l) = 400 L Vd >> TBW (0.6 x 100 kg) = 60 L, much of drug outside blood compartment The pharmacokinetic characteristics of drug X are: Bioavailability (oral) 1 % urinary excretion 100 Clearance (L/h/Kg) 0.1 x 100 Kg = 10 L/h Volume of distribution (L/Kg) MEC MTC 1 x 100 Kg = 100 L 1 mg/l 5 mg/l 17

The patient that you are administering drug X to is a 220 pound male with normal kidney function. Answer the following 4 questions. [2.2 pounds = 1 Kg] 220 pounds = 100 Kg What would be an appropriate plasma target level (Css and Cp) for drug X? a. 1 mg/l b. 2 mg/l c. 3 mg/l d. 4 mg/l e. 5 mg/l MEC 1 mg/l MTC 5 mg/l This drug is primarily cleared by the kinetics. a. kidney zero-order b. liver zero-order c. kidney first-order d. liver first-order e. liver and kidney mixed kinetics and follows % urinary excretion 100 % Clearance 0.1 L/h/Kg x 100 Kg = 10 L/h If it was zero order, clearance would not be stated as constant 18

Calculate a loading dose that would produce the appropriate Css. a. 100 mg b. 200 mg c. 300 mg d. 400 mg e. 500 mg LD = Vd x Cp F Vd = 1 L/kg x 100 kg = 100 L Oral F = 1.0 LD = (100 L x 3 mg/l) = 300 mg 1 Calculate the 4 h maintenance dose that would maintain the appropriate Css. a. 60 mg b. 120 mg c. 80 mg d. 160 mg e. 200 mg Css = [F x D] / [CL T] MD = [Css x CL x T]/F MD = [3 mg/l x 10 L/hr x 4 hr]/1 = 120 mg 19

The renal clearance of drugs that are weak acids and bases will be increased respectively by? a. sodium bicarbonate and ammonium chloride b. ammonium chloride and sodium bicarbonate c. amphetamine and aspirin d. antacids and phenobarbital e. aspirin and antacids f. probenecid and amphetamine For weak acid, to ionize, alkalinize (promotes formation of A-) For a weak base, to ionize, acidify (promotes formation of BH+) The absorption of tetracyclines and quinolones is reduced by all of the following except? a. antacids b. milk c. iron d. sodium e. magnesium Divalent cation decrease the absorption of these two classes of antimicrobials 20

If one wants to maintain a higher plasma level of drugs such as methotrexate or penicillin that are readily secreted by the kidney then one should administer which of the following agents? a. aspirin b. probenecid c. atropine d. cimetidine e. chloramphenicol f. phenobarbital Administer a drug that can compete for tubular secretion, same class as methotrexate or penicillin (acids), salicylic acid and probenecid are acids Bilirubin [kernicterus], tolbutamide [hypoglycemia] and dicumarol [hemorrage] are readily displaced from plasma albumin by all of the agents listed below except? a. aspirin b. phenobarbital c. sulfonamide d. salicylates e. cimetidine 21

Which of the following statements are true about epinephrine? a. prolongs the duration of action of local anesthetics b. interacts with imipramine to increase blood pressure c. increases capillary blood flow d. decreases blood pressure e. is a vasodilator 22